Bayer CropScience Ltd (BAYERCROP) is currently trading at 3,250.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Bayer CropScience Limited is the Indian subsidiary of Bayer AG focused on agriculture, operating across Crop Protection, Seeds & Traits and Digital Farming; it manufactures and sells insecticides, fungicides, herbicides and hybrid corn seeds, and runs breeding stations, processing and manufacturing facilities at Himatnagar, Silvassa, Hyderabad, Bengaluru and Udaipur to serve Indian farmers. In FY2025–26 the company reported Revenue from Operations of ₹56,750 million and Profit Before Tax of ₹8,549 million, with Q4 revenue at ₹11,008 million and Q4 PBT at ₹2,064 million; management highlighted 21% Profit After Tax growth for the year and recommended a final dividend of ₹60 per share, underlining cash generation and balance-sheet resilience. Product and seed momentum continued in FY26 with four new market introductions — Bicota, Felujit, Camalus and Mateno — expansion of the Xellano corn brand, and ongoing DEKALB releases; simultaneous breeding and plant‑health work, including Abacus‑Bio and Fusarium stalk rot diagnostics, show R&D translating into a visible commercial pipeline across crops and geographies. The company is pushing into farm digitization and plant health integration: Alivio’s initial rollout targets rainfed maize in Davanagere and Chhatrapati Sambhajinagar, offering soil‑moisture monitoring and assurance payouts, while internal R&D has established greenhouse assays and molecular diagnostics to manage stalk rots, indicating a coordinated digital‑bio approach to risk mitigation and yield protection. Management commentary emphasized disciplined channel management and cost control amid Kharif disruptions, describing a resilient but moderated topline (Q4 growth ~5%) and prioritizing quality‑led profitable growth over short‑term volume gains; CFO commentary stressed cash‑flow management and balance‑sheet flexibility to support strategic priorities and innovation investments.

Over the past 52 weeks, Bayer CropScience Ltd has traded between a low of ₹3,242.60 and a high of ₹5,055.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Bayer CropScience Ltd has a market capitalization of approximately 14,751.79. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Bayer CropScience Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 20.15 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 14,751.79 Cr, Bayer CropScience Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Bayer CropScience Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Bayer CropScience Ltd is 20.15. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

The provided data states Bayer CropScience’s share price is ₹4,068 as on 19 August 2026, with another cited NSE snapshot of ₹4,105.70 on 18 August (4:00 PM).

The AGM is scheduled for Wednesday, August 19, 2026 at 11:30 a.m. IST and will be conducted via VC/OAVM.

Total income in Q4FY26 was INR 11,474 million, up 2.25% QoQ and 5.90% YoY as per the disclosed figures.

The company informed BSE that its board will meet on August 5, 2026 to consider and approve unaudited results for the quarter ended June 30, 2026.